IUCRC Phase I UMN: Center for Integrated Material Science and Engineering of Pharmaceutical Products (CIMSEPP)

IUCRC 第一期 UMN:医药产品综合材料科学与工程中心 (CIMSEPP)

基本信息

  • 批准号:
    2137264
  • 负责人:
  • 金额:
    $ 59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2027-02-28
  • 项目状态:
    未结题

项目摘要

The pharmaceutical sector in America is a major, trillion-dollar industry, having broad impacts on the US population through benefits to their health and well-being. Despite US leadership, the industry is facing major problems, including, difficulties in developing newer molecules, high cost and lengthy time of bringing a new drug to market, lack of adequate and efficient regulatory science, consumer drug affordability, quality issues, and drug shortages. The COVID-19 pandemic has further exacerbated many of these challenges. These issues point to an acute need for innovative research and technical advances to develop high-quality drug products, achieve manufacturing efficiency, and support US-based pharmaceutical manufacturing. This IUCRC phase I project addresses such issues through establishing a joint two-university Center for Integrated Material Science and Engineering for Pharmaceutical Products (CIMSEPP), with New Jersey Institute of Technology (NJIT) as the Lead Site and University of Minnesota (UMN) as a Partner Site. Its mission is to advance and promote fundamental understanding of the material properties, drug-additive interactions at molecular and particulate level, as well as manufacturing processes, on product quality and performance, at lower cost.The CIMSEPP team will develop fundamental understanding of structure-function-performance of drug products and process engineering under three industry vetted Research Thrusts: A) Particle and Crystal Engineering, B) Model Predictive Understanding of Materials and Product Performance, and C) Bioavailability Enhancement and Stability. Research at CIMSEPP will 1) promote predictive enhancement of key properties of drugs, their engineered counterparts, and their blends for improving product quality, and 2) significantly reduce time and cost of drug product development. Key advances include, 1) identification of critical particle properties that impact fine particle behavior, 2) better understanding of their impact on cohesion and behaviors of powders, and 3) enabling accurate prediction of properties of blends as well as compacted tablets. That understanding will enable the development of mechanistic models and predictive tools required for efficient manufacturing of better products. The UMN team’s expertise in powder characterization and property enhancement through integrated crystal engineering and particle design will 1) enable the development of both highly effective and easy-to-adopt strategies to solve manufacturing problems and 2) contribute to the fundamental understanding of structure – property relationship through systematic research at length scales, ranging from molecular dimension to single crystal/particles, to powders, and to finished products.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
美国的制药业是一个主要的,万亿美元的产业,通过对美国人口的健康和福祉的好处,对他们产生广泛的影响。尽管美国处于领先地位,但该行业仍面临着重大问题,包括开发新分子的困难,将新药推向市场的成本高且时间长,缺乏充分有效的监管科学,消费者药物负担能力,质量问题和药物短缺。COVID-19大流行进一步加剧了其中许多挑战。这些问题表明迫切需要创新研究和技术进步,以开发高质量的药品,实现生产效率,并支持美国的制药业。这个IUCRC第一阶段项目通过建立一个联合两所大学的中心,为综合材料科学和工程的医药产品(CIMSEPP),与新泽西理工学院(NJIT)的领导网站和明尼苏达大学(UMN)作为合作伙伴网站解决这些问题。其使命是推进和促进对材料特性、分子和颗粒水平上的药物-添加剂相互作用以及生产工艺、产品质量和性能的基本理解,以更低的成本。CIMSEPP团队将在三个行业审查的研究重点下发展对药物产品和工艺工程的结构-功能-性能的基本理解:A)颗粒和晶体工程,B)材料和产品性能的模型预测理解,以及C)生物利用度增强和稳定性。 CIMSEPP的研究将1)促进药物,其工程对应物及其混合物的关键特性的预测增强,以提高产品质量,2)显着减少药物产品开发的时间和成本。 主要进展包括:1)识别影响细颗粒行为的关键颗粒特性,2)更好地了解它们对粉末凝聚力和行为的影响,以及3)能够准确预测混合物以及压实片剂的特性。这种理解将有助于开发有效制造更好产品所需的机械模型和预测工具。 UMN团队通过集成晶体工程和颗粒设计在粉末表征和性能增强方面的专业知识将1)能够开发高效和易于采用的策略来解决制造问题,2)通过长度尺度的系统研究,从分子尺寸到单晶/颗粒,再到粉末,该奖项反映了NSF的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect of drug loading and relative humidity on the mechanical properties and tableting performance of Celecoxib–PVP/VA 64 amorphous solid dispersions
载药量和相对湿度对塞来昔布·PVP/VA 64无定形固体分散体机械性能和压片性能的影响
  • DOI:
    10.1016/j.ijpharm.2023.123337
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Osei-Yeboah, Frederick;Sun, Changquan Calvin
  • 通讯作者:
    Sun, Changquan Calvin
Stress transmission coefficient is a reliable and robust parameter for quantifying powder plasticity
应力传递系数是量化粉末塑性的可靠且稳健的参数
  • DOI:
    10.1016/j.powtec.2021.117066
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    5.2
  • 作者:
    Vreeman, Gerrit;Sun, Changquan Calvin
  • 通讯作者:
    Sun, Changquan Calvin
Air entrapment during tablet compression – Diagnosis, impact on tableting performance, and mitigation strategies
片剂压缩过程中的空气滞留 — 诊断、对压片性能的影响以及缓解策略
  • DOI:
    10.1016/j.ijpharm.2022.121514
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Vreeman, Gerrit;Sun, Changquan Calvin
  • 通讯作者:
    Sun, Changquan Calvin
Understanding the role of magnesium stearate in lowering punch sticking propensity of drugs during compression
了解硬脂酸镁在降低压缩过程中药物冲头粘连倾向方面的作用
  • DOI:
    10.1016/j.ijpharm.2023.123016
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Gunawardana, Chamara A.;Kong, Angela;Wanapun, Debbie;Blackwood, Daniel O.;Travis Powell, C.;Krzyzaniak, Joseph F.;Thomas, Myles C.;Kresevic, John E.;Sun, Changquan Calvin
  • 通讯作者:
    Sun, Changquan Calvin
Worsened punch sticking by external lubrication with magnesium stearate
硬脂酸镁外部润滑导致冲头粘着恶化
  • DOI:
    10.1016/j.ijpharm.2023.123636
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    5.8
  • 作者:
    Xiang, Tianyi;Sun, Changquan Calvin
  • 通讯作者:
    Sun, Changquan Calvin
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Changquan Sun其他文献

A Study of Sulfamerazine Single Crystals Using Atomic Force Microscopy, Transmission Light Microscopy, and Raman Spectroscopy
  • DOI:
    10.1002/jps.20402
  • 发表时间:
    2005-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Xiaoping Cao;Changquan Sun;Thomas J. Thamann
  • 通讯作者:
    Thomas J. Thamann
Compaction Properties of L-Lysine Salts
  • DOI:
    10.1023/a:1011090510875
  • 发表时间:
    2001-01-01
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Changquan Sun;David J. W. Grant
  • 通讯作者:
    David J. W. Grant
Development of modified disodium hydrogen phosphate dodecahydrate/vermiculite composite phase change material and its application in radiant heat storage panel system
改性磷酸氢二钠十二水合物/蛭石复合相变材料的研制及其在辐射储热板系统中的应用
  • DOI:
    10.1016/j.enbuild.2025.115271
  • 发表时间:
    2025-02-15
  • 期刊:
  • 影响因子:
    7.100
  • 作者:
    Yue Han;Changquan Sun;Tao Xu;Dongpeng Zhu;Yanliang Du;Runhua He;Lingzhi Zhong;Hongqiang Ma
  • 通讯作者:
    Hongqiang Ma
Influence of Crystal Shape on the Tableting Performance of <span class="small-caps">L</span>‐Lysine Monohydrochloride Dihydrate
  • DOI:
    10.1002/1520-6017(200105)90:5<569::aid-jps1013>3.0.co;2-4
  • 发表时间:
    2001-05-01
  • 期刊:
  • 影响因子:
  • 作者:
    Changquan Sun;David J.W. Grant
  • 通讯作者:
    David J.W. Grant

Changquan Sun的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Changquan Sun', 18)}}的其他基金

I-Corps: Accelerated, materials sparing powder compaction characterization for improved pharmaceutical tablet formulation design
I-Corps:加速、节省材料的粉末压实表征,以改进药物片剂配方设计
  • 批准号:
    2341264
  • 财政年份:
    2023
  • 资助金额:
    $ 59万
  • 项目类别:
    Standard Grant
Planning IUCRC at University of Minnesota-Twin Cities: Center for Integrated Material Science and Engineering for Pharmaceutical Products (CIMSEPP)
明尼苏达大学双城分校规划 IUCRC:医药产品综合材料科学与工程中心 (CIMSEPP)
  • 批准号:
    1841363
  • 财政年份:
    2018
  • 资助金额:
    $ 59万
  • 项目类别:
    Standard Grant

相似国自然基金

Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 批准年份:
    2019
  • 资助金额:
    3350 万元
  • 项目类别:
    国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 批准年份:
    2018
  • 资助金额:
    12.0 万元
  • 项目类别:
    青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
  • 批准号:
    61675216
  • 批准年份:
    2016
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
基于Phase-type分布的多状态系统可靠性模型研究
  • 批准号:
    71501183
  • 批准年份:
    2015
  • 资助金额:
    17.4 万元
  • 项目类别:
    青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
  • 批准号:
    51201142
  • 批准年份:
    2012
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
  • 批准号:
    11101428
  • 批准年份:
    2011
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
  • 批准号:
    19374069
  • 批准年份:
    1993
  • 资助金额:
    6.4 万元
  • 项目类别:
    面上项目

相似海外基金

UK involvement in LSST: Phase C (Imperial component)
英国参与 LSST:C 阶段(帝国部分)
  • 批准号:
    ST/X001326/1
  • 财政年份:
    2025
  • 资助金额:
    $ 59万
  • 项目类别:
    Research Grant
Phase 2 - Effective and Integrated Chemical Free Robotic Milking
第 2 阶段 - 有效且集成的无化学品机器人挤奶
  • 批准号:
    10093094
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Collaborative R&D
Net Zero Pathfinder - Phase 2 Manchester
净零探路者 - 第二阶段曼彻斯特
  • 批准号:
    10095254
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Demonstrator
Phase Averaged Deferred Correction for Multi-Timescale Systems
多时间尺度系统的相位平均延迟校正
  • 批准号:
    EP/Y032624/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Research Grant
Model order reduction for fast phase-field fracture simulations
快速相场断裂模拟的模型降阶
  • 批准号:
    EP/Y002474/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Research Grant
IUCRC Phase I University of Wisconsin-Milwaukee: Center for Concrete Advancement Network (CAN), Lead Site
IUCRC 第一阶段威斯康星大学密尔沃基分校:混凝土进步网络中心 (CAN),主要站点
  • 批准号:
    2310861
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Continuing Grant
IUCRC Phase III University of Colorado Boulder: Center for Membrane Applications, Science and Technology (MAST)
IUCRC 第三阶段科罗拉多大学博尔德分校:膜应用、科学与技术中心 (MAST)
  • 批准号:
    2310937
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Continuing Grant
SBIR Phase II: Innovative Two-Phase Cooling with Micro Closed Loop Pulsating Heat Pipes for High Power Density Electronics
SBIR 第二阶段:用于高功率密度电子产品的创新两相冷却微闭环脉动热管
  • 批准号:
    2321862
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Cooperative Agreement
SBIR Phase I: Industrial-Scale Technology for Drug Development in Mature Human Fat Cells
SBIR 第一阶段:成熟人类脂肪细胞药物开发的工业规模技术
  • 批准号:
    2322443
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Standard Grant
STTR Phase II: Fabrication and Structural Testing of a 3D Concrete Printed Anchor for Floating Offshore Wind
STTR 第二阶段:用于浮动海上风电的 3D 混凝土打印锚的制造和结构测试
  • 批准号:
    2333306
  • 财政年份:
    2024
  • 资助金额:
    $ 59万
  • 项目类别:
    Cooperative Agreement
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了